Search Icon
CMRX Archived Articles

Chimerix (CMRX): Advancing Novel Therapies for Deadly Diseases

Published on November 19, 2024

Chimerix, Inc. (NASDAQ:CMRX): Advancing Dordaviprone for H3 K27M-Mutant Glioma with Promising Regulatory Pathways Emerging

Published on September 24, 2024